What we do
Corporate Governance Advisory Services
ESG Advisory Services
M&A and Information Agent Services
Capital Market Intelligence Services
Proxy Contests, Hostile Takeovers, Shareholder Activism and Special Situations
Proxy Solicitation and Shareholder Meeting Services
Retail Services and Additional Capabilities
Board of Director Services
Debt Services
SPAC Advisory Services
Services for Registered Funds - Mutual Funds, Exchange Traded Funds (ETFs) and Closed-End Funds - Di Costa Partners
Client Portal

Recent Mergers and Acquisitions

Celgene Corporation merger with Bristol-Myers Squibb

Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

Topics

Celgene Corporation merger with Bristol-Myers Squibb

Topics

Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

© 2016 - 2021 Morrow Sodali